Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123227052 | 12322705 | 2 | F | 20160613 | 20160502 | 20160708 | PER | US-PFIZER INC-2016222213 | PFIZER | 11.00 | YR | Y | 0.00000 | 20160708 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123227052 | 12322705 | 1 | PS | AZITHROMYCIN ANHYDROUS. | AZITHROMYCIN ANHYDROUS | 1 | UNK | U | 50710 | POWDER FOR ORAL SUSPENSION | |||||||||
| 123227052 | 12322705 | 2 | SS | QUILLIVANT XR | METHYLPHENIDATE HYDROCHLORIDE | 1 | UNK | U | 202100 | ORAL SUSPENSION |
Indications of drugs used
| no results found |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123227052 | 12322705 | Dyspnoea | |
| 123227052 | 12322705 | Oxygen saturation abnormal | |
| 123227052 | 12322705 | Sleep apnoea syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |